Asset Dedication, LLC Prothena Corp Public LTD CO Transaction History
Asset Dedication, LLC
- $1.46 Billion
- Q3 2024
A detailed history of Asset Dedication, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Asset Dedication, LLC holds 184 shares of PRTA stock, worth $3,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
184
Previous 184
-0.0%
Holding current value
$3,065
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
178Shares Held
42.8MCall Options Held
77.7KPut Options Held
92.7K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$193 Million8.45% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.24MShares$70.6 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$64.3 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.64MShares$60.6 Million0.01% of portfolio
-
State Street Corp Boston, MA1.93MShares$32.2 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $782M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...